SYN2BIO SPÓŁKA AKCYJNA

S2B · WAR · Healthcare / Biotechnology

64.00PLN+1.30 (+2.07%)

Price History

Full chart

Market Stats

Previous Close62.70

Open63.62

Day Range61.92 – 64.80

52-Week Range26.20 – 96.60

Volume8.08K

Market Cap581.36M

P/E (TTM)0.00

Forward P/E0.00

EPS-2.71

Dividend Yield0.00%

50-Day Avg65.75

200-Day Avg52.65

About

Syn2bio S.A. operates as a biotechnology company. It engages in the development and commercialization of SYN2 cardiotracer, a radiopharmaceutical designed for testing myocardial perfusion and diagnosis of coronary artery disease. It also engages in the research of new pharmaceutical compounds and its further study, registration, and market launch as a medicinal product. Syn2bio S.A. was incorporated in 2025 and is based in Warsaw, Poland.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Cezary Dariusz Kozanecki
Headquartersul. J. P. Dziekonskiego 3, Warsaw, Poland, 00-728, Poland
Websitehttps://syn2bio.pl/en

Leadership

Mr. Cezary Dariusz KozaneckiCEO & Chairman of the Management Board
Ms. Anna SzymanskaMember of the Management Board
Ms. Sawa Zuzanna ZarebinskaSecretary & Member of the Supervisory Board

Financials

Income Statement

Currency: PLN	2023-09-30	2024-09-30	2025-09-30
Total Revenue	0	0	0
Cost of Revenue	0	0	0
Gross Profit	0	0	0
Operating Expense	13.99M	19.89M	28.93M
Operating Income	-13.99M	-19.89M	-28.93M
EBITDA	-13.51M	-19.59M	-28.33M
Net Income	-11.85M	-16.34M	-23.66M
R&D	14.04M	19.92M	28.97M
Interest Expense	55.91K	45.31K	52.32K

Balance Sheet

Currency: PLN	2023-09-30	2024-09-30	2025-09-30
Total Assets	13.95M	20.20M	26.21M
Total Liabilities	2.53M	1.35M	9.53M
Total Equity	11.43M	18.85M	16.68M
Cash	5.98M	7.06M	7.22M

Cash Flow

Currency: PLN	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	-13.51M	-20.70M	-20.21M
Capital Expenditure	0	1.83M	878.17K
Free Cash Flow	-13.51M	-22.52M	-21.09M
FCF to OCF	100.00%	108.82%	104.35%

Key Statistics & Ratios

Market Cap581.36M

Enterprise Value593.56M

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.00

Price / Book17666.35

EPS-2.71

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding8.73M

Shares Float0

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%